ESPERION THERAPEUTICS INC
ESPRNASDAQ🏆 #2536 by market capEarnings Nov 4US Equity
$3.18▲ $0.00 (+0.00%)
Live1h—
24h▲ 0.0%
7d▼ 0.3%
14d▼ 0.3%
30d▼ 0.3%
1y▲ 77.2%
🏦Market Cap
$819M
Small Cap
📈Revenue Growth (YoY)
+61.1%
High Growth
📊Gross Margin
68.4%
High
💵FCF Margin
10.8%
Healthy
⚖️P/S Ratio
2.0x
Cheap
Otter Score
50
Weak
Earnings
Q2 · 2026Reported 2026-05-08Earnings Per Share
Actual
-0.10
Expected
-0.04
miss
−150.00%
YoY +52.40%
Revenue
Actual
$80.10M
Expected
$84.52M
miss
−5.20%
YoY +23.20%
Consensus estimates
Recent quarters
Q2 2026
-0.10
miss
Q1 2026
0.22
miss
Q4 2025
-0.16
miss
Q3 2025
-0.02
beat